Literature DB >> 30804162

Rare cause of subarachnoid haemorrhage.

Anandbir Singh Bath1, Dominika M Zoltowska1, Yashwant Agrawal2, Vishal Gupta3.   

Abstract

Entities:  

Keywords:  adult intensive care; infectious diseases; valvar diseases

Mesh:

Substances:

Year:  2019        PMID: 30804162      PMCID: PMC6388790          DOI: 10.1136/bcr-2018-229093

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


× No keyword cloud information.
  3 in total

1.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  J Am Coll Cardiol       Date:  2014-03-03       Impact factor: 24.094

2.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Authors:  Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

3.  HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.

Authors:  Stephen T Chambers; David Murdoch; Arthur Morris; David Holland; Paul Pappas; Manel Almela; Nuria Fernández-Hidalgo; Benito Almirante; Emilio Bouza; Davide Forno; Ana del Rio; Margaret M Hannan; John Harkness; Zeina A Kanafani; Tahaniyat Lalani; Selwyn Lang; Nigel Raymond; Kerry Read; Tatiana Vinogradova; Christopher W Woods; Dannah Wray; G Ralph Corey; Vivian H Chu
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.